240 related articles for article (PubMed ID: 36555326)
21. Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.
Shima R; Li TC; Sendai Y; Kataoka C; Mori Y; Abe T; Takeda N; Okamoto T; Matsuura Y
Sci Rep; 2016 Feb; 6():21638. PubMed ID: 26905478
[TBL] [Abstract][Full Text] [Related]
22. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles.
Lu T; Behloul N; Zhou Y; Baha S; Liu Z; Wei W; Shi RH; Meng J
Intervirology; 2022; 65(1):37-48. PubMed ID: 34695827
[TBL] [Abstract][Full Text] [Related]
24. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin.
Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonossoff GP; Ravin NV
Bioengineered; 2016; 7(1):28-32. PubMed ID: 26710263
[TBL] [Abstract][Full Text] [Related]
25. Efficient production and characterization of immunogenic HEV-PCV2 chimeric virus-like particles.
Baha S; Zhang M; Behloul N; Liu Z; Wei W; Meng J
Vet Microbiol; 2022 May; 268():109410. PubMed ID: 35421831
[TBL] [Abstract][Full Text] [Related]
26. Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana.
Regnard GL; Rybicki EP; Hitzeroth II
Virol J; 2017 Sep; 14(1):174. PubMed ID: 28893289
[TBL] [Abstract][Full Text] [Related]
27. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
[TBL] [Abstract][Full Text] [Related]
29. New viral vector for superproduction of epitopes of vaccine proteins in plants.
Tyulkina LG; Skurat EV; Frolova OY; Komarova TV; Karger EM; Atabekov IG
Acta Naturae; 2011 Oct; 3(4):73-82. PubMed ID: 22649706
[TBL] [Abstract][Full Text] [Related]
30. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
[TBL] [Abstract][Full Text] [Related]
31. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
32. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
[TBL] [Abstract][Full Text] [Related]
33. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
34. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
Zheng M; Jiang J; Zhang X; Wang N; Wang K; Li Q; Li T; Lin Q; Wang Y; Yu H; Gu Y; Zhang J; Li S; Xia N
Vaccine; 2018 Apr; 36(16):2104-2111. PubMed ID: 29544686
[TBL] [Abstract][Full Text] [Related]
35. Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.
Qi Y; Fan J; Huang W; Zhao C; Wang Y; Kong FT; Kong W; Jiang C
Biotechnol Appl Biochem; 2016 May; 63(3):362-70. PubMed ID: 25824972
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
37. Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants.
Nemchinov LG; Natilla A
Protein Expr Purif; 2007 Dec; 56(2):153-9. PubMed ID: 17644356
[TBL] [Abstract][Full Text] [Related]
38. The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus.
Haqshenas G; Huang FF; Fenaux M; Guenette DK; Pierson FW; Larsen CT; Shivaprasad HL; Toth TE; Meng XJ
J Gen Virol; 2002 Sep; 83(Pt 9):2201-2209. PubMed ID: 12185274
[TBL] [Abstract][Full Text] [Related]
39. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
[TBL] [Abstract][Full Text] [Related]
40. [Fermentation, purification and immunogenicity evaluation of hepatitis E virus-like particles expressed in Hansenula polymorpha].
Su C; Li L; Jin Z; Han X; Zhao P; Wang L; Jiang C; Wang Y; Wang W; Xu D; Zhu N
Sheng Wu Gong Cheng Xue Bao; 2017 Apr; 33(4):653-663. PubMed ID: 28920398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
